AIIMS researchers develop innovative CAR-T cell therapy for Multiple Myeloma, marking a breakthrough in blood cancer treatment
NEW DELHI: AIIMS Delhi has developed an antibody-based therapy for recurrent cancers, particularly Multiple Myeloma (MM), marking a significant advancement…